Evidence map›Paper›PMID 36158541›Full record

ArticleFrontiers in aging neuroscience2022

Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6.

Valeria Isella, Daniele Licciardo, Francesca Ferri, Cinzia Crivellaro, Sabrina Morzenti, Ildebrando Appollonio, Carlo Ferrarese

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Differences in neuropsychological performance across clinical variants of progressive supranuclear palsy.Journal of the International Neuropsychological Society : JINS · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Valeria IsellaDepartment of Neurology, School of Medicine, University of Milano - Bicocca, Monza, Italy.
Daniele LicciardoMilan Center for Neurosciences, Milan, Italy.
Francesca FerriMilan Center for Neurosciences, Milan, Italy.
Cinzia CrivellaroNuclear Medicine Unit, San Gerardo Hospital, Monza, Italy.
Sabrina MorzentiMedical Physics, San Gerardo Hospital, Monza, Italy.
Ildebrando AppollonioDepartment of Neurology, School of Medicine, University of Milano - Bicocca, Monza, Italy.
Carlo FerrareseDepartment of Neurology, School of Medicine, University of Milano - Bicocca, Monza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Reduced phonemic fluency is extremely frequent in progressive supranuclear palsy (PSP), but its neural correlate is yet to be defined. Objective: We explored the hypothesis that poor fluency in PSP might be due to neurodegeneration within a dominant frontal circuit known to be involved in speech fluency, including the opercular area, the superior frontal cortex (BA6), and the frontal aslant tract connecting these two regions. Methods: We correlated performance on a letter fluency task (F, A, and S, 60 s for each letter) with brain metabolism as measured with Fluoro-deoxy-glucose Positron Emission Tomography, using Statistical Parametric Mapping, in 31 patients with PSP. Results: Reduced letter fluency was associated with significant hypometabolism at the level of left BA6. Conclusion: Our finding is the first evidence that in PSP, as in other neurogical disorders, poor self-initiated, effortful verbal retrieval appears to be linked to dysfunction of the dominant opercular-aslant-BA6 circuit.

Indexed as

FDG-PETfluencyfrontal aslant tractprogressive supranuclear palsysupplementary motor area

Identifiers

PMID36158541
PMCPMC9492952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.